ArticleCurrent oncology (Toronto, Ont.)2025

Real-World Experience with CDK4/6 Inhibitors in the First-Line Palliative Setting for HR+/HER2- Advanced Breast Cancer.

Ram Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.